iShares U.S. Pharmaceuticals ETF (IHE)
| Assets | $688.52M |
| Expense Ratio | 0.40% |
| PE Ratio | 6.55 |
| Shares Out | 10.20M |
| Dividend (ttm) | $2.17 |
| Dividend Yield | 3.27% |
| Ex-Dividend Date | Mar 21, 2024 |
| Payout Ratio | 21.41% |
| 1-Year Return | +12.28% |
| Volume | 12,914 |
| Open | 66.04 |
| Previous Close | 66.07 |
| Day's Range | 65.87 - 66.36 |
| 52-Week Low | 55.36 |
| 52-Week High | 69.56 |
| Beta | n/a |
| Holdings | 38 |
| Inception Date | May 1, 2006 |
About IHE
Fund Home PageThe iShares U.S. Pharmaceuticals ETF (IHE) is an exchange-traded fund that is based on the DJ US Select / Pharmaceutical index. The fund tracks a broad-based, cap-weighted index of US pharmaceutical companies. IHE was launched on May 1, 2006 and is issued by BlackRock.
Top 10 Holdings
79.70% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 22.99% |
| Johnson & Johnson | JNJ | 22.59% |
| Merck & Co., Inc. | MRK | 4.94% |
| Pfizer Inc. | PFE | 4.90% |
| Zoetis Inc. | ZTS | 4.42% |
| Royalty Pharma plc | RPRX | 4.27% |
| Viatris Inc. | VTRS | 4.19% |
| Catalent, Inc. | CTLT | 4.09% |
| Bristol-Myers Squibb Company | BMY | 3.84% |
| Elanco Animal Health Incorporated | ELAN | 3.46% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 21, 2024 | $0.27502 | Mar 27, 2024 |
| Dec 20, 2023 | $0.404 | Dec 27, 2023 |
| Sep 26, 2023 | $0.902 | Oct 2, 2023 |
| Jun 7, 2023 | $0.590 | Jun 13, 2023 |
| Mar 23, 2023 | $0.672 | Mar 29, 2023 |
| Dec 13, 2022 | $1.337 | Dec 19, 2022 |
News
Why investor appetite for commodity funds picked up despite ETF flows broadly seeing ‘pretty big drop' in April
Hello! This week's ETF Wrap digs into the slump in ETF flows in April and investor positioning around commodities as inflation worries persist.
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade
A new ETF hit the market Tuesday, creating buzz for its exposure to popular weight-loss drugs, while expanding the roster of thematic ETFs available for investors willing to pay up for stock-picking p...
Best Pharmaceutical ETFs for Q1 2021
The best pharmaceutical ETFs for Q1 2021 are KURE, XPH, and IHE.